Skip to main content
. 2022 Apr 30;16:11795549221090186. doi: 10.1177/11795549221090186

Table 5.

Comparison of response between fluoropyrimidine-based regimen and gemcitabine-based regimen for metastatic PACC.

Gemcitabine-based Fluoropyrimidine-based P value
Cases ORR (%) Cases ORR (%)
Our study First line (n = 8) 3 0 (0) 5 4 (80) >.05
Second line (n = 4) 2 0 (0) 2 2 (100) >.05
Literatures First line (n = 86) 39 6 (15.3) 47 28 (59.6) <.001
Second line (n = 29) 10 1 (10.0) 19 10 (52.6) <.05

Abbreviations: ORR, objective response rate; PACC, pancreatic acinar cell carcinoma.